Show simple item record

dc.contributor.authorScase, TJ
dc.contributor.authorEdwards, D
dc.contributor.authorMiller, J
dc.contributor.authorHenley, W
dc.contributor.authorSmith, K
dc.contributor.authorBlunden, A
dc.contributor.authorMurphy, S
dc.date.accessioned2019-06-26T15:33:51Z
dc.date.issued2006-01-01
dc.description.abstractThe Patnaik histologic grading system is commonly used to predict the behavior of cutaneous mast cell tumors (MCTs) in dogs, but it is less useful for grade 2 MCTs because they exhibit considerable variation in biological behavior. In this retrospective study, immunohistochemical staining for Ki-67, proliferating cell nuclear antigen (PCNA), and survivin and a standardized argyrophilic staining of nucleolar organizer regions (AgNOR) protocol were performed on 121 archived paraffin-embedded specimens of canine cutaneous MCTs, for which clinical follow-up data were available. Cox regression models indicated that the Ki-67 score (hazard ratio, 1.92; P < .001) and mean AgNOR score (hazard ratio, 2.57; P < .001) were significantly associated with Patnaik grade and survival time. A binary Ki-67 variable (cutoff point Ki-67 score = 1.8) was a significant predictor of survival for dogs with grade 2 MCTs. The estimated 1-, 2-, and 3-year survival probabilities for dogs with grade 2 MCTs and Ki-67 scores less than 1.8 were 0.92, 0.86, and 0.77, respectively (SEs, 0.08, 0.14, and 0.23, respectively; median not estimable). The corresponding survival probabilities for dogs with grade 2 MCTs and Ki-67 scores higher than 1.8 were 0.43, 0.21, and 0.21, respectively (SEs, 0.19, 0.18, and 0.18, respectively; median survival time, 395 days). No significant association was identified between survival and survivin score or PCNA score. This study shows that both mean AgNOR score and Ki-67 score are prognostic markers for canine MCTs. The Ki-67 score can be used to divide Patnaik grade 2 MCTs into 2 groups with markedly different expected survival times. Copyright © 2006 by the American College of Veterinary Internal Medicine.en_GB
dc.identifier.citationVol. 20 (1), pp. 151 - 158en_GB
dc.identifier.doi10.1111/j.1939-1676.2006.tb02835.x
dc.identifier.urihttp://hdl.handle.net/10871/37694
dc.language.isoenen_GB
dc.publisherWiley for American College of Veterinary Internal Medicineen_GB
dc.rights© 2006 American College of Veterinary Internal Medicineen_GB
dc.subjectAgNORen_GB
dc.subjectInhibitor of apoptosisen_GB
dc.subjectKi‐67en_GB
dc.subjectPCNAen_GB
dc.titleCanine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosisen_GB
dc.typeArticleen_GB
dc.date.available2019-06-26T15:33:51Z
dc.identifier.issn0891-6640
dc.descriptionThis is the final version. Available on open access from Wiley via the DOI in this recorden_GB
dc.identifier.journalJournal of Veterinary Internal Medicineen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
pubs.euro-pubmed-idMED:16496935
dcterms.dateAccepted2005-07-06
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2006-01-01
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-06-26T15:32:20Z
refterms.versionFCDVoR
refterms.dateFOA2019-06-26T15:33:54Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record